|
|
|
|
|
|
|
|
|
|
White Papers
|
National Pharmaceutical Council (NPC)
|
 |
About Us
|
|
NPC was established in 1953 and is supported by the nation’s major research-based pharmaceutical companies. While NPC’s overarching mission remains to sponsor and conduct scientific analyses of the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation, in 2007 NPC announced a new strategic focus on evidence-based medicine (EBM) for health care decision-making. |
|
The Patient-Centered Outcomes Research Institute Research Guide 
Summary: NPC’s
Patient-Centered Outcomes Research Institute Resource Guide was created to
foster better understanding of the role of the PCORI Board of Governors and of
issues related to comparative effectiveness research (CER). This guide provides
specifics concerning PCORI’s implementation, biographies of the new PCORI
Board members, a history of CER in the United States, and other relevant
resources.
|
Resources for Medicare Beneficiaries: Using Your Medicare Drug Plan
Summary: This 12-page publication explains what to do when your medicines aren’t covered by your Medicare Part D plan, such as how and when to go through your plan’s appeals process and how to use an appointed representative. This brochure also includes a sample redetermination request letter for Medicare beneficiaries.
|
Resources for Medicare Beneficiaries: Navigating the Coverage Gap | How the Gap May Affect You
Summary: This six-page brochure explains who may be affected by the Medicare Part D coverage gap; discusses how the coverage gap works and offers suggestions on how to avoid it; and provides tips on how to track covered drug expenses, including a sample expense log.
|
National Institute for Health and Clinical Excellence (NICE): How Does It Work? (Executive summary)
Summary: This study, authored by Dr. Michael Drummond and his colleagues at the London School of Economics, provides an overview of the U.K.’s National Institute for Health and Clinical Excellence (NICE) and offers conclusions about what the U.K.'s experiences mean for establishing a more formalized system for collecting comparative effectiveness information in the U.S.
|
National Institute for Health and Clinical Excellence (NICE): How Does It Work? (Full study)
Summary: This four-part study, commissioned by the National Pharmaceutical Council, examines the U.K.’s National Institute for Health and Clinical Excellence (NICE) and its operations, as well as the implications for comparative effectiveness reviews in the United States. NICE is the organization that provides guidance to the U.K.’s National Health Service on the clinical and economic effects of various medical treatments.
|
The Current Evidence-based Medicine Landscape
Summary: This reference guide identifies and documents the relevant organizations, activities, proposals, and key individuals associated with the evidence-based medicine (EBM) movement in the United States. The guide also addresses other EBM practices, including comparative effectiveness and health technology assessment.
|
|
|
